Atrial fibrillation (AF) is the most common cardiac arrhythmia found in clinical practice
and a frequent cause of hospital admission. AF is associated with a 5-fold increased
risk of stroke and an approximately 2-fold increased risk of death, in addition to also
being associated with heart failure development.[1]Approximately 20 years ago, the percutaneous radiofrequency ablation of the pulmonary
veins (PVs) was described by Haissaguerre et al.[2] as an effective technique and curative treatment of paroxysmal
AF (PAF). The initial technique of AF ablation was developed based on the observation
that the electrical activity triggers (ectopic foci), responsible for causing PAF, are
frequently located in the PVs. As a consequence, the initiation of PAF could be
prevented through the ablation of these triggers.[2]Subsequently, aiming to prevent potential procedure complications, such as PV stenosis,
and also to improve its success rates, the PV ablation procedure was progressively
modified, from the PV focal ablation technique to the segmental electrical isolation of
the PV ostia, resulting in the predominant present-day technique of extended
circumferential antral ablation of PVs (1 to 2 cm extended area from the PV
ostia).[1,3]Most of the available data[1,3] indicate that the circumferential antral
ablation of the PVs is more effective than the ostial ablation of the PVs. The
beneficial mechanisms of PV circumferential antral ablation are not fully established
but are probably related to the isolation of the triggers in the PV antrum, the
modification of the ganglionated plexi, or the interruption of AF initiation and/or
maintenance mechanisms located within the PV antrum.[1,3]The most frequent PV circumferential antral ablation technique uses radiofrequency
energy, delivered point-by-point through an external irrigated-tip catheter, with the
help of a three-dimensional, electroanatomical mapping system as a navigation guide and
also for the creation of a visual record of the ablated sites.More recently, irrigated catheters have become available, with contact force-sensing
technology, which is able to measure the contact force intensity between the tip of the
catheter and the myocardium, increasing the effectiveness of the radiofrequency ablation
lesion in the myocardium, and reducing procedure complication rates.[1] Cryoablation, which uses a
balloon-catheter to attain PV isolation, is an equally validated alternative
technique.[1]Currently, the shortcoming of the PV circumferential ablation is the AF recurrence during
the first year after the ablation, an event typically related to the electrical
reconnection of PVs to the left atrium.[1] Therefore, several lines of research are focused on identifying
techniques and procedures that can provide a permanent electrical isolation of the PVs
during the initial AF ablation procedure.In this context, in the current issue of the Arquivos Brasileiros de Cardiologia,
Odozynski et al.,[4] report the results
of circumferential antral ablation of the PVs in PAF treatment, specifically comparing
patients who had a common trunk of the left PVs (CTrL) versus those without CTrL.An electroanatomical mapping system based on chest impedance was used in all procedures
and patients underwent circumferential isolation of the VP antrum by delivering
radiofrequency with an irrigated-tip catheter but without monitoring the contact force,
aiming at obtaining entrance and exit block into the PVs.In the present study, in agreement with the world's literature, approximately 17% of the
patients had a CTrL. It should be emphasized that during the medium-term clinical
follow-up, a lower recurrence rate of AF was observed in patients with CTrL when
compared to patients without CTrL.[4]The current study has the merit of providing a timely overview of the complexity found in
the present-day percutaneous ablation of PVs, discussing the implications that PV
anatomy can have on PAF ablation outcome. As reported in the study, four pulmonary veins
reach the left atrium in most patients. The CTrL, defined as the fusion of the 2 left
PVs into a common trunk, is the most common anatomical variation of the PVs, occurring
in 4% to 18% of patients undergoing AF ablation.[5]As pointed out by the authors, the possible reason for patients with CTrL to show a lower
recurrence rate of PAF could be related to the fact that it is easier to handle and
attain better contact between the ablation catheter and the left atrium in patients
presenting with CTrL.[4] As previously
reported,[1,3] the intensity of the contact force between the ablation
catheter and the myocardium is crucial for the radiofrequency lesion formation and has
been associated with longer-lasting PV isolation and better clinical outcomes.Furthermore, as already has been discussed, circumferential antral ablation of the PVs is
more effective than the ostial ablation of the PVs, probably related to the isolation of
the triggers in the antrum of the PVs, modification of the ganglionated plexi, or the
interruption of AF initiation and/or maintenance mechanisms located within the PV
antrum.
Authors: Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane Journal: Heart Rhythm Date: 2017-05-12 Impact factor: 6.343
Authors: Riccardo Proietti; Pasquale Santangeli; Luigi Di Biase; Jacqueline Joza; Martin Louis Bernier; Yang Wang; Antonio Sagone; Maurizio Viecca; Vidal Essebag; Andrea Natale Journal: Circ Arrhythm Electrophysiol Date: 2014-01-02
Authors: M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty Journal: N Engl J Med Date: 1998-09-03 Impact factor: 91.245